Please login to the form below

Not currently logged in
Email:
Password:

Pharma market access [infographic]

A 12 step process for preparing a pharma brand for market

Pharma market access infographic

There is no 'one' definition of market access – the idea of which varies from company to company; region to region.

But while there may not be consensus on the exact wording – which spans everything from 'stakeholders' to 'accelerate market uptake', 'optimising value' and 'pricing and reimbursement' – most agree that it is not a 'discipline' that can be packaged neatly into a silo.

Inside: Market Access, a new publication from PMLiVE's publishers PMGroup, provides expert thinking on the area and includes a unique market access road map.

Download full size infographic on 12 steps to prepare a pharma brand for market (pdf - right click and select 'save link as')

Pharma market access reportThe publication, which PME subscribers received earlier this month, also looks at:

• Re-positioning pharma's image for market access success
• How to equip market access teams for local challenges
• The role of communication and education
• The true meaning of market access
• UK market access and the NHS
• How NICE is collaborating, and exporting its thinking, across Europe and beyond
• EU pricing and reimbursement, and reference pricing.

View Inside: Market Access online

28th June 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

blog-icon_build_your_argumentation.png
Build your e-detailing argumentation
We’ve written a number of posts recently giving insights into the Anthill method for structuring e-detailing & CLM presentations. To help you overview, we’ve put these argumentation posts together....
Growing influence of pharmacists in the sale of Rx and OTC medicines
Find out how the changes within pharmacy have affected their influence over the sales of RX and OTC medicines in this whitepaper....
Drivers of 2014′s Soaring Drug Approvals
The FDA & EMA approved a chart-topping number of new drugs in 2014. Read more in our White Paper about the responsibility this growing approval success will put on future...